HSBC Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History

HSBC Holdings’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,680	Closed	-$403K	–	2802
2018 Q1	$403K	Sell	20,680 -400,690	-95%	-$7.86M	﹤0.01%	2053
2017 Q4	$7.02M	Buy	+421,370	New	+$7.72M	0.01%	769
2017 Q1	–	Sell	-13,760	Closed	-$182K	–	2809
2016 Q4	$182K	Buy	+13,760	New	+$235K	﹤0.01%	2547
2015 Q2	–	Sell	-4,425	Closed	-$208K	–	2351
2015 Q1	$208K	Buy	+4,425	New	+$176K	﹤0.01%	1910
2013 Q3	–	Sell	-10,000	Closed	-$200K	–	1827
2013 Q2	$200K	Buy	+10,000	New	+$178K	﹤0.01%	1443

HSBC Holdings's IPXL Position: Q2 2018 in Review

HSBC Holdings sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 20,680 shares — an estimated $403K sold.

HSBC Holdings first reported a position in IPXL in Q2 2013 and held it in 5 quarters. The position peaked at $7.02M in Q4 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

HSBC Holdings reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
HSBC Holdings sold 20,680 Impax Laboratories, Inc. shares in Q2 2018, an estimated $403K.
HSBC Holdings first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 5 quarters.
HSBC Holdings's Impax Laboratories, Inc. position peaked at $7.02M in Q4 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on HSBC Holdings's 13F filing for Q2 2018, filed 10 Aug 2018.